WO1997004788A3 - Use of calendula glycosides for the treatment of psoriasis - Google Patents

Use of calendula glycosides for the treatment of psoriasis Download PDF

Info

Publication number
WO1997004788A3
WO1997004788A3 PCT/GB1996/001792 GB9601792W WO9704788A3 WO 1997004788 A3 WO1997004788 A3 WO 1997004788A3 GB 9601792 W GB9601792 W GB 9601792W WO 9704788 A3 WO9704788 A3 WO 9704788A3
Authority
WO
WIPO (PCT)
Prior art keywords
psoriasis
calendula
glycosides
treatment
compounds
Prior art date
Application number
PCT/GB1996/001792
Other languages
French (fr)
Other versions
WO1997004788A2 (en
Inventor
Solomon Habtemarium
William Howard Stimson
Alexander Irvine Gray
Chaman Lal Anand
Peter George Waterman
Original Assignee
Univ Strathclyde
Solomon Habtemarium
William Howard Stimson
Alexander Irvine Gray
Chaman Lal Anand
Peter George Waterman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US09/000,265 priority Critical patent/US6225342B1/en
Priority to AU66210/96A priority patent/AU6621096A/en
Priority to PL96324655A priority patent/PL324655A1/en
Priority to DE69627354T priority patent/DE69627354T2/en
Application filed by Univ Strathclyde, Solomon Habtemarium, William Howard Stimson, Alexander Irvine Gray, Chaman Lal Anand, Peter George Waterman filed Critical Univ Strathclyde
Priority to AT96925837T priority patent/ATE236643T1/en
Priority to BR9609910A priority patent/BR9609910A/en
Priority to JP50733497A priority patent/JP4384261B2/en
Priority to EP96925837A priority patent/EP0848612B1/en
Priority to SK94-98A priority patent/SK9498A3/en
Priority to EE9800032A priority patent/EE9800032A/en
Publication of WO1997004788A2 publication Critical patent/WO1997004788A2/en
Publication of WO1997004788A3 publication Critical patent/WO1997004788A3/en
Priority to IS4651A priority patent/IS4651A/en
Priority to NO980317A priority patent/NO980317L/en
Priority to BG102250A priority patent/BG102250A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Abstract

Use of glycosidic compounds as pharmaceutical agents against psoriasis, compounds therefor and pharmaceutical formulations thereof.
PCT/GB1996/001792 1995-07-25 1996-07-24 Use of calendula glycosides for the treatment of psoriasis WO1997004788A2 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
BR9609910A BR9609910A (en) 1995-07-25 1996-07-24 Use of a compound compound is mere physiologically functional pharmaceutical formulation for the treatment of psoriasis and process for treating skin disease involving hyperproliferation of skin cells in a mammal
PL96324655A PL324655A1 (en) 1995-07-25 1996-07-24 Application of marigold glycosides in treating psoriasis
DE69627354T DE69627354T2 (en) 1995-07-25 1996-07-24 USE OF CALENDULA GLYCOSIDES FOR TREATING PSORIASIS
EP96925837A EP0848612B1 (en) 1995-07-25 1996-07-24 Use of calendula glycosides for the treatment of psoriasis
AT96925837T ATE236643T1 (en) 1995-07-25 1996-07-24 USE OF CALENDULA GLYCOSIDES TO TREAT PSORIASIS
AU66210/96A AU6621096A (en) 1995-07-25 1996-07-24 Use of calendula glycosides for the treatment of psoriasis
JP50733497A JP4384261B2 (en) 1995-07-25 1996-07-24 Use of calendula glucoside for the treatment of psoriasis
US09/000,265 US6225342B1 (en) 1995-07-25 1996-07-24 Use of calendula glycosides for the treatment of psoriasis
SK94-98A SK9498A3 (en) 1995-07-25 1996-07-24 Use of calendula glycosides for the treatment of psoriasis
EE9800032A EE9800032A (en) 1995-07-25 1996-07-24 Use of calendula glycosides for the treatment of psoriasis
IS4651A IS4651A (en) 1995-07-25 1998-01-16 Use of glyphosides (VAN-1OX compounds) from yellowfin for the treatment of psoriasis
NO980317A NO980317L (en) 1995-07-25 1998-01-23 Use of Calendula glycosides for the treatment of psoriasis
BG102250A BG102250A (en) 1995-07-25 1998-02-13 The use of marigold-extracted glycosides for the treatment of psoriasis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9515214.6 1995-07-25
GBGB9515214.6A GB9515214D0 (en) 1995-07-25 1995-07-25 Plant extracts

Publications (2)

Publication Number Publication Date
WO1997004788A2 WO1997004788A2 (en) 1997-02-13
WO1997004788A3 true WO1997004788A3 (en) 1997-03-27

Family

ID=10778203

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1996/001792 WO1997004788A2 (en) 1995-07-25 1996-07-24 Use of calendula glycosides for the treatment of psoriasis

Country Status (22)

Country Link
US (1) US6225342B1 (en)
EP (1) EP0848612B1 (en)
JP (1) JP4384261B2 (en)
KR (1) KR19990035847A (en)
CN (1) CN1191488A (en)
AT (1) ATE236643T1 (en)
AU (1) AU6621096A (en)
BG (1) BG102250A (en)
BR (1) BR9609910A (en)
CA (1) CA2227751A1 (en)
CZ (1) CZ19498A3 (en)
DE (1) DE69627354T2 (en)
EE (1) EE9800032A (en)
ES (1) ES2197242T3 (en)
GB (1) GB9515214D0 (en)
HU (1) HUP9802861A3 (en)
IS (1) IS4651A (en)
NO (1) NO980317L (en)
PL (1) PL324655A1 (en)
SK (1) SK9498A3 (en)
WO (1) WO1997004788A2 (en)
ZA (1) ZA966298B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6753006B1 (en) 1993-02-22 2004-06-22 American Bioscience, Inc. Paclitaxel-containing formulations
GB9701415D0 (en) * 1997-01-24 1997-03-12 Univ Strathclyde Stereoisomers
GB9809889D0 (en) 1998-05-11 1998-07-08 Univ Strathclyde Prevention of restenosis
WO2001003712A1 (en) * 1999-07-09 2001-01-18 Astion Development Aps Composition containing extracts of butyrospermum parkii and the use as medicament or dietary supplement
US6440465B1 (en) * 2000-05-01 2002-08-27 Bioderm, Inc. Topical composition for the treatment of psoriasis and related skin disorders
US20050003023A1 (en) * 2002-06-28 2005-01-06 Meisner Lorraine Faxon Topical composition for the treatment of psoriasis and related skin disorders
US20030054042A1 (en) * 2001-09-14 2003-03-20 Elaine Liversidge Stabilization of chemical compounds using nanoparticulate formulations
US7887860B2 (en) * 2001-12-28 2011-02-15 Inter American University Of Puerto Rico Anti-bacterial plant compositions
CA2479665C (en) * 2002-03-20 2011-08-30 Elan Pharma International Ltd. Nanoparticulate compositions of angiogenesis inhibitors
US20080220075A1 (en) * 2002-03-20 2008-09-11 Elan Pharma International Ltd. Nanoparticulate compositions of angiogenesis inhibitors
US20050152996A1 (en) * 2003-12-01 2005-07-14 BUTLER Donald Extracts of Mimulus aurantiacus for treating psoriasis and repelling insects
BG65694B1 (en) * 2003-12-31 2009-07-31 Владимир НАЙДЕНОВ Means for the treatment of dermatoses
US20060076536A1 (en) * 2004-09-29 2006-04-13 Barshied Scott R Oxygen scavenging pharmaceutical package and methods for making same
PL409156A1 (en) 2014-08-11 2016-02-15 Matonis Grzegorz Cosmetic and/or pharmaceutical composition having soothing effect on the psoriasis symptoms
US10966948B2 (en) 2019-07-23 2021-04-06 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
KR20210038636A (en) 2018-07-27 2021-04-07 존슨 앤드 존슨 서지컬 비전, 인코포레이티드 Composition and method for eye treatment
US11197841B2 (en) 2019-07-23 2021-12-14 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
CN109516983A (en) * 2018-11-20 2019-03-26 广东药科大学 A kind of Chinese medicine draft anti-acne compound and combinations thereof
CN114159453A (en) 2021-12-24 2022-03-11 广西馨海药业科技有限公司 Application of pulsatilla chinensis saponin B4 in preparation of medicine for treating or preventing psoriasis

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3836519A1 (en) * 1988-10-26 1990-05-03 Cutan Kosmetik Vertriebs Gmbh Pharmaceutical composition based on Calendula officinalis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU610551B2 (en) 1987-12-23 1991-05-23 Psoricur Ltd. Therapeutical compositions against psoriasis
HU203668B (en) 1990-04-03 1991-09-30 Tamas Angeli Cosmetic containing medicinal plants and process for producing composition against psoriasis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3836519A1 (en) * 1988-10-26 1990-05-03 Cutan Kosmetik Vertriebs Gmbh Pharmaceutical composition based on Calendula officinalis

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
A. A AHMED: "Sesquiterpene glycosides from Calendula arvensis", J. NAT. PROD., vol. 56, no. 10, 1993, pages 1821 - 1824, XP000604343 *
C. PIZZA: "Sesquiterpene glycosides based on the alloaromadendrane skeleton from Calendula arvensis", PHYTOCHEM., vol. 27, no. 7, 1988, pages 2205 - 2208, XP000604400 *
D. TAKAOKA: "The structures of sesquiterpene glycosides from Pittosporum tobira Ait", CHEM. LETT., no. 7, 1986, pages 1121 - 1124, XP002024377 *
J JAKUPOVIC: "Sesquiterpene glycosides from Calendula persica", PLANTA MED, vol. 54, no. 3, 1988, pages 254 - 256, XP000604346 *
J. JAKUPOVIC: "Sesquiterpene glycosides and other constituents from Osteospermum species", PHYTOCHEM., vol. 27, no. 9, 1988, pages 2881 - 2886, XP000617061 *
N. DE TOMASSI: "Structure and in vitro antiviral acitvity of sesquiterpene glycosides from Calendula arvensis", J. NAT. PROD., vol. 53, no. 4, 1990, pages 830 - 835, XP000604341 *

Also Published As

Publication number Publication date
CA2227751A1 (en) 1997-02-13
MX9800697A (en) 1998-09-30
WO1997004788A2 (en) 1997-02-13
CZ19498A3 (en) 1998-09-16
EP0848612A2 (en) 1998-06-24
AU6621096A (en) 1997-02-26
GB9515214D0 (en) 1995-09-20
SK9498A3 (en) 1998-09-09
KR19990035847A (en) 1999-05-25
HUP9802861A2 (en) 1999-04-28
ES2197242T3 (en) 2004-01-01
DE69627354T2 (en) 2004-03-04
PL324655A1 (en) 1998-06-08
EE9800032A (en) 1998-08-17
ATE236643T1 (en) 2003-04-15
US6225342B1 (en) 2001-05-01
DE69627354D1 (en) 2003-05-15
JPH11510153A (en) 1999-09-07
CN1191488A (en) 1998-08-26
IS4651A (en) 1998-01-16
JP4384261B2 (en) 2009-12-16
BR9609910A (en) 1999-06-15
BG102250A (en) 1999-02-26
HUP9802861A3 (en) 1999-08-30
NO980317L (en) 1998-03-24
NO980317D0 (en) 1998-01-23
EP0848612B1 (en) 2003-04-09
ZA966298B (en) 1997-02-11

Similar Documents

Publication Publication Date Title
WO1997004788A3 (en) Use of calendula glycosides for the treatment of psoriasis
NZ333380A (en) 6-O-methylerythromycin A crystal form I (clarithromycin) and preparation thereof
AU679663B2 (en) Dermatological or pharmaceutical composition, preparation process and use
HUP9601566A3 (en) Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component
AU2053597A (en) Pharmaceutical compositions for the treatment of glaucoma
AU6373094A (en) Enzyme-containing pharmaceutical or cosmetic composition, process for preparing the same and its use
HUP0004421A3 (en) Urea derivatives and pharmaceutical compositions containing them, use thereof for the treatment of deseases mediated by impdh enzyme
AU2977695A (en) Compositions for applying active substances to or through the skin
AU3892593A (en) Composition for therapeutic or diagnostic use, process for its preparation and its use
MX9704034A (en) Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and compositions and method of use thereof.
AU5526898A (en) Isomeric pharmaceutical formulation containing dfmo for the treatment of cancer
DK0719276T3 (en) Estradiol esters with strong oral action as well as pharmaceutical preparations containing them
AU8851298A (en) L-threonate ferrous, as well as pharmaceutical composition and use for improvingand treating human anemia thereof
AU4994996A (en) Composition for the treatment of diarrhea, its use and its preparation
ATE181324T1 (en) SECO-D STEROIDS ACTIVE IN THE CARDIOVASCULAR SYSTEM AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME
AU3896899A (en) Compositions for the treatment of tumors, and uses thereof
IL110780A0 (en) Pharmaceutical compositions containing 1,3-bis(2-carboxy-chromon-5-yloxy)-propan-2-ol for the treatment of the common cold
AU5699396A (en) Compositions for the treatment of skin conditions
HK1050203A1 (en) Novel fusidic acid derivatives.
AU5494298A (en) Pharmaceutical compositions for the treatment of the eye
AU5818096A (en) Topical aciclovir preparation
AU4882897A (en) Disinfectant composition, particularly for the prevention of dermatitis induced by diapers, and method for its use
AU6611094A (en) Benzylidene hydantoin derivative, ultraviolet ray absorbent and external preparation for skin including the same
AU5771198A (en) Use of stereoisomers of calendula glycosides for the treatment of psoriasis
AU6208594A (en) Gastrokinetic agent, process for its preparation and pharmaceutical compositions containing said agent

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 96195818.9

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1996925837

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: PV1998-194

Country of ref document: CZ

ENP Entry into the national phase

Ref document number: 2227751

Country of ref document: CA

Ref document number: 2227751

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 9498

Country of ref document: SK

Ref document number: PA/a/1998/000697

Country of ref document: MX

Ref document number: 313684

Country of ref document: NZ

Ref document number: 1019980700507

Country of ref document: KR

Ref document number: 98-00113

Country of ref document: RO

ENP Entry into the national phase

Ref document number: 1997 507334

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 09000265

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1996925837

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: PV1998-194

Country of ref document: CZ

WWP Wipo information: published in national office

Ref document number: 1019980700507

Country of ref document: KR

WWR Wipo information: refused in national office

Ref document number: PV1998-194

Country of ref document: CZ

WWW Wipo information: withdrawn in national office

Ref document number: 1019980700507

Country of ref document: KR

WWG Wipo information: grant in national office

Ref document number: 1996925837

Country of ref document: EP